With regard to the papers by Kumar et al. and de Leeuw and de Boer addressing the cardiovascular safety and efficacy of anti-diabetic drugs

Affiliations

¹ Cardiac Safety Services, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
² Diabetes Center of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
³ Office of the Chief Medical & Scientific Officer, 4820 Emperor Blvd, Durham, NC 27703, USA.
⁴ Research Team, Cardiac Safety Services, QuintilesIMS, 602 Western Express Highway, Andheri East, Mumbai 400 069, India.
⁵ Cardiac Safety Services, Cardiac Safety Center of Excellence, QuintilesIMS, 602 Western Express Highway, Andheri East, Mumbai 400 069, India.
⁶ Therapeutic and Specialty Centers of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
⁷ Cardiovascular Center of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.

Comment

J Rick Turner et al. Eur Heart J Cardiovasc Pharmacother. 2017.

. 2017 Apr 1;3(2):75-76.

doi: 10.1093/ehjcvp/pvw047.

¹ Cardiac Safety Services, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
² Diabetes Center of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
³ Office of the Chief Medical & Scientific Officer, 4820 Emperor Blvd, Durham, NC 27703, USA.
⁴ Research Team, Cardiac Safety Services, QuintilesIMS, 602 Western Express Highway, Andheri East, Mumbai 400 069, India.
⁵ Cardiac Safety Services, Cardiac Safety Center of Excellence, QuintilesIMS, 602 Western Express Highway, Andheri East, Mumbai 400 069, India.
⁶ Therapeutic and Specialty Centers of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.
⁷ Cardiovascular Center of Excellence, QuintilesIMS, 4820 Emperor Blvd, Durham, NC 27703, USA.

No abstract available

Comment on

Cardiovascular safety of anti-diabetic drugs.
Kumar R, Kerins DM, Walther T. Kumar R, et al. Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):32-43. doi: 10.1093/ehjcvp/pvv035. Epub 2015 Sep 7. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533060 Review.
Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects.
de Leeuw AE, de Boer RA. de Leeuw AE, et al. Eur Heart J Cardiovasc Pharmacother. 2016 Oct;2(4):244-55. doi: 10.1093/ehjcvp/pvw009. Epub 2016 Apr 18. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533948 Review.